Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: J Clin Pharmacol. 2015 Mar 30;55(7):798–808. doi: 10.1002/jcph.481

Table 1.

Data are number (%) or Mean (SD) for plasma and genital viral loads (VL). Rebound is detectable virus after achieving < 50 copies/mL.

	Plasma			Genital
	ATV n=9	EFV n=11	P-value	ATV n=9	EFV n=11	P-value
Baseline log₁₀ VL	4.39 (1.02)	4.66 (0.95)	0.545	3.25 (1.27)	3.23 (0.86)	0.9
VL <50 copies/mL	5 (56%)	9 (82%)	0.336	8 (89%)	11 (100%)	0.5
Rebound	1 (20%)	1 (11%)	0.604	1 (20%)	1 (11%)	0.6
Days to VL < 50	109.6 (71.5)	77.1 (5.7)	0.394	23.3 (9.5)	25.8 (14.5)	0.9
Days to 50% decline in VL	8.2 (4.9)	9.3 (7.4)	0.707	7.3 (3.5)	9.3 (7.7)	0.5
Days to >1 log₁₀ drop in VL	56.3 (119.1)	12.7 (10.1)	0.305	62.9 (136.0)	25.0 (43.4)	0.5
End of study log₁₀ VL	1.98 (0.61)	2.79 (1.68)	0.129	1.93 (0.50)	2.54 (1.25)	0.1